Plate Nº 90 · recorded October 10, 2026
Health & Medicine ResearchReported finding
One TikTok Video Drove 36.6% of Acetaminophen-Autism Misinformation Views
After the FDA's Sept. 22, 2025 Tylenol label announcement, one TikTok misinformation video drew 10.3 million views — 36.6% of all exposure in a 53-video study.
By Priya Raman4 min read762 words
In brief
- Researchers analyzed 53 TikTok videos posted September–November 2025; about 53% were evidence-consistent and about 28% contained misinformation.
- One misinformation video reached 10.3 million views, accounting for 36.6% of all exposure in the study.
- The FDA announced the acetaminophen label change on Sept. 22, 2025.
- Nearly three-quarters of misinformation videos came from influencers rather than medical professionals.
- The findings were presented at the AAP 2026 National Conference & Exhibition, Oct. 2–6, 2026, in San Diego.

A single TikTok misinformation video about acetaminophen and autism racked up 10.3 million views — more than a third (36.6%) of all exposure in the content researchers analyzed. The finding comes from a study presented at the American Academy of Pediatrics 2026 National Conference & Exhibition, held Oct. 2–6, 2026, at the San Diego Convention Center.
The research examined what happened on TikTok after the Food and Drug Administration announced a label change for acetaminophen products such as Tylenol on Sept. 22, 2025. That announcement triggered widespread confusion and concern, and many users went online looking for reliable answers. On TikTok, they were more likely to run into misinformation from influencers with no medical training.
What did the researchers actually find?
The team, working with an abstract titled "Acetaminophen Use During Pregnancy and Autism on TikTok: Disproportionate Exposure to Misinformation in a Content Analysis," analyzed 53 TikTok videos posted between September and November 2025, after the FDA announcement. The results split into three broad groups:
- About 53% of the videos contained information consistent with scientific evidence.
- About 28% contained outright misinformation.
- Misinformation videos drew disproportionate attention despite being a minority of the content.
"Despite being a smaller portion of the overall available subject content, the misinformation videos accounted for over half of the total views of all the content we examined," said Shivani Srivastava, a medical student at Rutgers School of Medicine who worked on the study.
Nearly three-quarters of the misinformation videos came from influencers rather than medical professionals. That gap matters because influencers typically optimize for engagement, not accuracy, and the platform's recommendation system rewards whatever keeps viewers watching.
Why did the misinformation spread so far?
The study points to TikTok's recommendation algorithm as a key factor. "Our results indicate that TikTok's algorithm amplified low-quality, conspiracy-framed videos containing misinformation on a very sensitive health topic and allowed for misinformation videos to spread far wider than evidence-based videos that explained the lack of evidence of a causal link between prenatal acetaminophen exposure and autism," Srivastava said.
In plain terms: videos claiming a causal link between the common painkiller and autism reached far more people than videos explaining that no solid evidence supports such a link. The mechanism is the platform's engagement-driven ranking, which gave conspiracy-framed content a visibility advantage over evidence-based explanations on the same topic.
The timing amplified the effect. The FDA's Sept. 22, 2025 announcement prompted a surge of searches from worried parents and pregnant patients. When accurate institutional content was scarce or less engaging, the algorithm filled the demand with influencer videos making stronger, simpler — and unsupported — claims.
How did the study come about?
The project started in the clinic, not the lab. "After seeing pregnant patients in our own clinics question whether it was safe to take Tylenol during pregnancy, we wanted to understand what information they were being exposed to online," Srivastava said.
That clinical observation led the team to systematically catalog and classify TikTok content posted in the wake of the FDA announcement, separating evidence-consistent videos from misinformation and tracking how many views each category received.
What are the study's limitations?
The findings come from an abstract presented at a conference, meaning the work has not yet undergone the full peer-review process of a published journal article. The sample is also narrow: 53 videos posted over roughly three months on a single platform, covering one health topic after one specific regulatory announcement. The results may not generalize to other platforms, other topics, or longer time windows.
The study also measures exposure, not outcomes. It shows that misinformation dominated views, but it does not directly test whether viewers changed their medication behavior as a result.
What should doctors and patients take from it?
The researchers argue that as more people turn to social media — especially TikTok — for medical advice, pediatricians need to proactively address misinformation with patients and their families rather than waiting for questions to arrive at the clinic.
"Our findings reveal how important it is for medical institutions to be part of the conversations on social media by sharing accurate, engaging content that reaches patients where they are," Srivastava said.
The practical implication is twofold. Clinicians should expect patients to arrive with beliefs shaped by viral videos, and they should be prepared to discuss the actual evidence on prenatal acetaminophen use. Medical institutions, meanwhile, may need to meet patients on the platforms where the misinformation is spreading — with content accurate enough to trust and engaging enough to compete.
via Medical Xpress (Source)
More from Priya Raman
Show full bio
Senior reporter covering industry trends and analytics at SciBeat.
207 articles
Nearby plates
- Alzheimer's Drug Developers Accuse Trial Sites of Faking Data
- FDA Urges Drug Makers to Release Data From Thousands of Unpublished Trials
- Open Science Resource Aims to Speed Digital Health Research in Autism
- Fixing Brain Blood Vessels Reverses Autism Symptoms in Mice
- Doctors Can't Trace AI Chatbot Health Harm, Researchers Warn